Vaccination-based exposure to spike protein derived from early SARS-CoV-2 sequences is
the key public health strategy against COVID-19. Successive waves of SARS-CoV-2 …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recently identified
coronavirus that causes the respiratory disease known as coronavirus disease 2019 (COVID-19)…

Vaccines based on the spike protein of SARS-CoV-2 are a cornerstone of the public health
response to COVID-19. The emergence of hypermutated, increasingly transmissible variants …

The recent emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),
the underlying cause of Coronavirus Disease 2019 (COVID-19), has led to a worldwide …

At the end of 2021 a new SARS-CoV-2 variant, Omicron, emerged and quickly spread across
the world. It has been demonstrated that Omicron’s high number of Spike mutations lead to …

… MacLean, Craig Wilkie, Giuditta De Lorenzo, Wilhelm Furnon, Diego Cantoni, Sam Scott,
Nicola Logan and Shirin Ashraf contributed equally and that John Haughney, David L …

The appearance of new dominant variants of concern (VOC) of severe acute respiratory
syndrome coronavirus type 2 (SARS-CoV-2) threatens the global response to the coronavirus …

SARS-CoV-2 has a broad mammalian species tropism infecting humans, cats, dogs, and
farmed mink. Since the start of the 2019 pandemic, several reverse zoonotic outbreaks of SARS…

Zika virus (ZIKV) emerged on a global scale and no licensed vaccine ensures long-lasting
anti-ZIKV immunity. Here we report the design and comparative evaluation of four replication-…

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) human adaptation
resulted in distinct lineages with enhanced transmissibility called variants of concern (VOCs). …